Lumizyme Articles
Genzyme to invest 250 million euros for Belgian plant to support growth of Myozyme and Lumizyme
21 January 2011
Good news at last for Genzyme, which gets FDA approval for Lumizyme earlier than anticipated
26 May 2010
Showing 1-3 of 3 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
